Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction

Journal of Controlled Release

Volumn 170, Issue 2, 2013, Pages 287-294

  Chang, Ming Yao ^a   Yang, Yu Jen ^a   Chang, Chih Han ^a   Tang, Alan C L ^a   Liao, Wei Yin ^a   Cheng, Fong Yu ^a   Yeh, Chen Sheng ^a   Lai, James J ^b   Stayton, Patrick S ^b   Hsieh, Patrick C H ^a,b,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b University of Washington   (United States)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Akt; Apoptosis; Cardiomyocyte; Heart failure; Insulin like growth factor 1

Indexed keywords

ACTIVATION ANALYSIS; CELL DEATH; DIAGNOSIS; DISEASE CONTROL; DISEASES; INSULIN; NANOPARTICLES; NANOTECHNOLOGY; ORGANIC POLYMERS; PHOSPHORYLATION; TISSUE REGENERATION;

ACUTE MYOCARDIAL INFARCTION; CARDIO-VASCULAR DISEASE; CARDIOMYOCYTES; FUNCTIONALIZED NANOPARTICLES; HEART FAILURE; INSULIN-LIKE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR-1; POLY(D ,L-LACTIDE-CO-GLYCOLIDE);

CARDIOLOGY;

DOXORUBICIN; NANOPARTICLE; POLYGLACTIN; PROTEIN KINASE B; SOMATOMEDIN C; ANTINEOPLASTIC ANTIBIOTIC; CARDIOTONIC AGENT; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATIC ELECTRICITY; THERAPY EFFECT; WESTERN BLOTTING; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HEART VENTRICLE; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CARDIOTONIC AGENTS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HEART VENTRICLES; INSULIN-LIKE GROWTH FACTOR I; LACTIC ACID; MALE; MICE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NANOPARTICLES; POLYGLYCOLIC ACID; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84879471846     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.04.022     Document Type: Article

References (47)

1. A.D. Lopez, C.D. Mathers, M. Ezzati, D.T. Jamison, C.J. Murray, Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data, Lancet 367 (2006) 1747-1757. (Pubitemid 43767064)
2. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, T.M. Brown, M.R. Carnethon, S. Dai, G. de Simone, E.S. Ford, C.S. Fox, H.J. Fullerton, C. Gillespie, K.J. Greenlund, S.M. Hailpern, J.A. Heit, P.M. Ho, V.J. Howard, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, D.M. Makuc, G.M. Marcus, A. Marelli, D.B. Matchar, M.M. McDermott, J.B. Meigs, C.S. Moy, D. Mozaffarian, M.E. Mussolino, G. Nichol, N.P. Paynter, W.D. Rosamond, P.D. Sorlie, R.S. Stafford, T.N. Turan, M.B. Turner, N.D. Wong, J. Wylie-Rosett, o.b.o.t.A.H.A.S. Committee, Stroke Statistics Subcommittee, O.b.o.t.A.H.A.H. Disease, Stroke Statistics Writing Group, Heart disease and stroke statistics - 2011 update: a report from the American Heart Association, Circulation 123 (2011) e18-e209.
3. E.D. Adler, J.Z. Goldfinger, J. Kalman, M.E. Park, D.E. Meier, Palliative care in the treatment of advanced heart failure, Circulation 120 (2009) 2597-2606.
4. M. Jessup, S. Brozena, Heart failure, N. Engl. J. Med. 348 (2003) 2007-2018.
5. B. Nadal-Ginard, J. Kajstura, A. Leri, P. Anversa, Myocyte death, growth, and regeneration in cardiac hypertrophy and failure, Circ. Res. 92 (2003) 139-150. (Pubitemid 36254270)
6. L. Wang, W. Ma, R. Markovich, J.W. Chen, P.H. Wang, Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I, Circ. Res. 83 (1998) 516-522. (Pubitemid 28411053)
7. K. Reiss, W. Cheng, A. Ferber, J. Kajstura, P. Li, B. Li, G. Olivetti, C.J. Homcy, R. Baserga, P. Anversa, Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice, Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 8630-8635. (Pubitemid 26269611)
8. R.L. Duerr, S. Huang, H.R. Miraliakbar, R. Clark, K.R. Chien, J. Ross Jr., Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure, J. Clin. Invest. 95 (1995) 619-627.
9. M.Y. Donath, G. Sutsch, X.W. Yan, B. Piva, H.P. Brunner, Y. Glatz, J. Zapf, F. Follath, E.R. Froesch, W. Kiowski, Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure, J. Clin. Endocrinol. Metab. 83 (1998) 3177-3183. (Pubitemid 28500953)
10. M. Palmen, M.J. Daemen, R. Bronsaer, W.R. Dassen, H.R. Zandbergen, M. Kockx, J.F. Smits, R. van der Zee, P.A. Doevendans, Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice, Cardiovasc. Res. 50 (2001) 516-524. (Pubitemid 32480245)
11. C.M. Prele, M.E. Reichelt, S.E. Mutsaers, M. Davies, L.M. Delbridge, J.P. Headrick, N. Rosenthal, M.A. Bogoyevitch, M.D. Grounds, Insulin-like growth factor-1 overexpression in cardiomyocytes diminishes ex vivo heart functional recovery after acute ischemia, Cardiovasc. Pathol. 21 (2011) 17-27.
12. P.C. Hsieh, M.E. Davis, J. Gannon, C. MacGillivray, R.T. Lee, Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers, J. Clin. Invest. 116 (2006) 237-248. (Pubitemid 43121809)
13. P.C.H. Hsieh, C. MacGillivray, J. Gannon, F.U. Cruz, R.T. Lee, Local controlled intramyocardial delivery of platelet-derived growth factor improves postinfarction ventricular function without pulmonary toxicity, Circulation 114 (2006) 637-644. (Pubitemid 44252305)
14. Y.D. Lin, M.L. Yeh, Y.J. Yang, D.C. Tsai, T.Y. Chu, Y.Y. Shih, M.Y. Chang, Y.W. Liu, A.C. Tang, T.Y. Chen, C.Y. Luo, K.C. Chang, J.H. Chen, H.L. Wu, T.K. Hung, P.C. Hsieh, Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs, Circulation 122 (2010) S132-S141.
15. M.J. Webber, J. Tongers, M.A. Renault, J.G. Roncalli, D.W. Losordo, S.I. Stupp, Development of bioactive peptide amphiphiles for therapeutic cell delivery, Acta Biomater. 6 (2010) 3-11.
16. N. Landa, L. Miller, M.S. Feinberg, R. Holbova, M. Shachar, I. Freeman, S. Cohen, J. Leor, Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat, Circulation 117 (2008) 1388-1396. (Pubitemid 351506386)
17. K.L. Christman, R.J. Lee, Biomaterials for the treatment of myocardial infarction, J. Am. Coll. Cardiol. 48 (2006) 907-913. (Pubitemid 44292446)
18. W. Dai, L.E. Wold, J.S. Dow, R.A. Kloner, Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction, J. Am. Coll. Cardiol. 46 (2005) 714-719. (Pubitemid 41132703)
19. K.L. Christman, A.J. Vardanian, Q. Fang, R.E. Sievers, H.H. Fok, R.J. Lee, Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium, J. Am. Coll. Cardiol. 44 (2004) 654-660. (Pubitemid 39089073)
20. M.E. Davis, P.C. Hsieh, T. Takahashi, Q. Song, S. Zhang, R.D. Kamm, A.J. Grodzinsky, P. Anversa, R.T. Lee, Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction, Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 8155-8160. (Pubitemid 43801068)
21. J.C. Sy, G. Seshadri, S.C. Yang, M. Brown, T. Oh, S. Dikalov, N. Murthy, M.E. Davis, Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction, Nat. Mater. 7 (2008) 863-868.
22. V. Wagner, A. Dullaart, A.K. Bock, A. Zweck, The emerging nanomedicine landscape, Nat. Biotechnol. 24 (2006) 1211-1217. (Pubitemid 44564760)
23. A.E. Nel, L. Madler, D. Velegol, T. Xia, E.M.V. Hoek, P. Somasundaran, F. Klaessig, V. Castranova, M. Thompson, Understanding biophysicochemical interactions at the nano-bio interface, Nat. Mater. 8 (2009) 543-557.
24. J. Shi, A.R. Votruba, O.C. Farokhzad, R. Langer, Nanotechnology in drug delivery and tissue engineering: from discovery to applications, Nano Lett. 10 (2010) 3223-3230.
25. P. Decuzzi, B. Godin, T. Tanaka, S.Y. Lee, C. Chiappini, X. Liu, M. Ferrari, Size and shape effects in the biodistribution of intravascularly injected particles, J. Control. Release 141 (2010) 320-327.
26. R.A. Petros, J.M. DeSimone, Strategies in the design of nanoparticles for therapeutic applications, Nat. Rev. Drug Discov. 9 (2010) 615-627.
27. M.L. Schipper, G. Iyer, A.L. Koh, Z. Cheng, Y. Ebenstein, A. Aharoni, S. Keren, L.A. Bentolila, J. Li, J. Rao, X. Chen, U. Banin, A.M. Wu, R. Sinclair, S. Weiss, S.S. Gambhir, Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice, Small 5 (2009) 126-134.
28. D.S. Kohane, Microparticles and nanoparticles for drug delivery, Biotechnol. Bioeng. 96 (2007) 203-209. (Pubitemid 46232255)
29. S. Mitragotri, J. Lahann, Physical approaches to biomaterial design, Nat. Mater. 8 (2009) 15-23.
30. A. Hoshino, K. Fujioka, T. Oku, M. Suga, Y.F. Sasaki, T. Ohta, M. Yasuhara, K. Suzuki, K. Yamamoto, Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification, Nano Lett. 4 (2004) 2163-2169.
31. F. Yang, Y.H. Liu, X.P. Yang, J. Xu, A. Kapke, O.A. Carretero, Myocardial infarction and cardiac remodelling in mice, Exp. Physiol. 87 (2002) 547-555. (Pubitemid 35012228)
32. S. Dhar, N. Kolishetti, S.J. Lippard, O.C. Farokhzad, Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo, Proc. Natl. Acad. Sci. U. S. A. 108 (2011) 1850-1855.
33. S. Sengupta, D. Eavarone, I. Capila, G. Zhao, N. Watson, T. Kiziltepe, R. Sasisekharan, Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system, Nature 436 (2005) 568-572. (Pubitemid 41112931)
34. K.A. Woodrow, Y. Cu, C.J. Booth, J.K. Saucier-Sawyer, M.J. Wood, W. Mark Saltzman, Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA, Nat. Mater. 8 (2009) 526-533.
35. M. Kitakaze, S. Takashima, H. Funaya, T. Minamino, K. Node, Y. Shinozaki, H. Mori, M. Hori, Temporary acidosis during reperfusion limits myocardial infarct size in dogs, Am. J. Physiol. 272 (1997) H2071-H2078.
36. Y. Yeghiazarians, Y. Zhang, M. Prasad, H. Shih, S.A. Saini, J. Takagawa, R.E. Sievers, M.L. Wong, N.K. Kapasi, R. Mirsky, J. Koskenvuo, P. Minasi, J. Ye, M.N. Viswanathan, F.S. Angeli, A.J. Boyle, M.L. Springer, W. Grossman, Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy, Mol. Ther. 17 (2009) 1250-1256.
37. C. Borghi, S. Boschi, E. Ambrosioni, G. Melandri, A. Branzi, B. Magnani, Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors, J. Clin. Pharmacol. 33 (1993) 40-45. (Pubitemid 23067505)
38. N. Freemantle, J. Cleland, P. Young, J. Mason, J. Harrison, Beta blockade after myo-cardial infarction: systematic review and meta regression analysis, BMJ 318 (1999) 1730-1737. (Pubitemid 29290470)
39. S. Aso, H. Ise, M. Takahashi, S. Kobayashi, H. Morimoto, A. Izawa, M. Goto, U. Ikeda, Effective uptake of N-acetylglucosamine-conjugated liposomes by cardiomyocytes in vitro, J. Control. Release 122 (2007) 189-198. (Pubitemid 47364749)
40. W.D. Gray, P. Che, M. Brown, X. Ning, N. Murthy, M.E. Davis, N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing, J. Cardiovasc. Transl. Res. 4 (2011) 631-643.
41. Y. Wu, W. Wang, Y. Chen, K. Huang, X. Shuai, Q. Chen, X. Li, G. Lian, The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro, Int. J. Nanomedicine 5 (2010) 129-136.
42. P. Anversa, J. Kajstura, A. Leri, R. Bolli, Life and death of cardiac stem cells: a paradigm shift in cardiac biology, Circulation 113 (2006) 1451-1463. (Pubitemid 43739442)
43. J.M. Koziara, P.R. Lockman, D.D. Allen, R.J. Mumper, In situ blood-brain barrier transport of nanoparticles, Pharm. Res. 20 (2003) 1772-1778. (Pubitemid 37449450)
44. K. Yamashita, Y. Yoshioka, K. Higashisaka, K. Mimura, Y. Morishita, M. Nozaki, T. Yoshida, T. Ogura, H. Nabeshi, K. Nagano, Y. Abe, H. Kamada, Y. Monobe, T. Imazawa, H. Aoshima, K. Shishido, Y. Kawai, T. Mayumi, S. Tsunoda, N. Itoh, T. Yoshikawa, I. Yanagihara, S. Saito, Y. Tsutsumi, Silica and titanium dioxide nanoparticles cause pregnancy complications in mice, Nat. Nanotechnol. 6 (2011) 321-328.
45. A. Nel, T. Xia, L. Madler, N. Li, Toxic potential of materials at the nanolevel, Science 311 (2006) 622-627. (Pubitemid 43191298)
46. H. Fujii, Z. Sun, S.H. Li, J. Wu, S. Fazel, R.D. Weisel, H. Rakowski, J. Lindner, R.K. Li, Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice, JACC Cardiovasc. Imaging 2 (2009) 869-879.
47. T. Dvir, M. Bauer, A. Schroeder, J.H. Tsui, D.G. Anderson, R. Langer, R. Liao, D.S. Kohane, Nanoparticles targeting the infarcted heart, Nano Lett. 11 (2011) 4411-4414.